Early identification and better characterization of the prodromal phase of psychotic illness can lead to targeted treatment and perhaps prevention of many of the devastating effects of a first psychotic episode. The primary aim of this manuscript is to describe the treatment histories of a large cohort of individuals who entered into one of seven prodromal research programs in a North American Prodrome Longitudinal Study consortium
